HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
The Latest in Amyloidosis Research With Heather Landau, MD, Memorial Sloan Kettering Cancer Center
The Latest in Amyloidosis Research With Heather Landau, MD, Memorial Sloan Kettering Cancer Center image
HealthTree Podcast for Multiple Myeloma
event Feb 28, 2017 / 11:00AM - 12:00PM MST

Event Description

Heather Landau, MD Memorial Sloan Kettering Cancer Center Interview Date: February 28,  2017 

 Many multiple myeloma patients can also have amyloidosis - or protein buildup in specific organs. Dr. Heather Landau of the Memorial Sloan Kettering cancer center explains the different kinds of amyloidosis, current treatments and exciting clinical trials for these patients. These trials include myeloma drugs such as Ninlaro, carfilzomib, daratumumab and other standard treatments, but also a new drug called NEOD001 that can reverse amyloidosis in certain organs. This is a very informative show for amyloidosis patients with or without multiple myeloma.

multiple myeloma

Thanks to our episode sponsor

Schedule & Agenda

person
Discussion
11:00AM
Dr. Heather Landau & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube